{ "cik": 1823239, "cik_padded": "0001823239", "entityName": "MARAVAI LIFESCIENCES HOLDINGS, INC.", "fiscal_years": [ { "accn": "0001823239-26-000011", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13149000.0, "cash": 216890000.0, "cost_of_revenue": 151753000.0, "eps_diluted": -0.9, "free_cash_flow": -70722000.0, "gross_profit": 33990000.0, "net_income": -130773000.0, "operating_cash_flow": -57573000.0, "operating_income": -215266000.0, "revenue": 185743000.0, "stockholders_equity": 212379000.0, "total_assets": 770577000.0, "total_liabilities": 397866000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.1829947831143031, "leverage": 1.8733773113160905, "net_margin": -0.7040534501973157, "operating_margin": -1.1589454245920439, "revenue_growth_yoy": -0.28335744738314333, "roa_avg2y": -0.14703334399582646, "roa_period_end": -0.16970789421433546, "roe_avg2y": -0.4864424527266674, "roe_period_end": -0.6157529699264052 } }, { "accn": "0001823239-26-000011", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 29658000.0, "cash": 322399000.0, "cost_of_revenue": 150876000.0, "eps_diluted": -1.05, "free_cash_flow": -22193000.0, "gross_profit": 108309000.0, "net_income": -144846000.0, "operating_cash_flow": 7465000.0, "operating_income": -235617000.0, "revenue": 259185000.0, "stockholders_equity": 325292000.0, "total_assets": 1008244000.0, "total_liabilities": 431035000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.41788297933908214, "leverage": 1.3250710131205194, "net_margin": -0.558851785404248, "operating_margin": -0.9090688118525379, "revenue_growth_yoy": -0.10299537974354982, "roa_avg2y": -0.11607673056071778, "roa_period_end": -0.1436616533299479, "roe_avg2y": -0.3903968088188722, "roe_period_end": -0.44527993310625535 } }, { "accn": "0001823239-26-000011", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 65553000.0, "cash": 574962000.0, "cost_of_revenue": 148743000.0, "eps_diluted": -0.9, "free_cash_flow": 60671000.0, "gross_profit": 140202000.0, "net_income": -119029000.0, "operating_cash_flow": 126224000.0, "operating_income": -31648000.0, "revenue": 288945000.0, "stockholders_equity": 416753000.0, "total_assets": 1487450000.0, "total_liabilities": 697566000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.4852203706587759, "leverage": 1.6738115862393312, "net_margin": -0.4119434494453962, "operating_margin": -0.10952949523265673, "revenue_growth_yoy": -0.6727693400120724, "roa_avg2y": -0.06314929445204144, "roa_period_end": -0.08002218561968472, "roe_avg2y": -0.2474689985456942, "roe_period_end": -0.2856104215206609 } }, { "accn": "0001823239-25-000034", "filed": "2025-03-18", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 17090000.0, "cash": 632138000.0, "eps_diluted": 1.67, "free_cash_flow": 518887000.0, "net_income": 220205000.0, "operating_cash_flow": 535977000.0, "operating_income": 574216000.0, "revenue": 883001000.0, "stockholders_equity": 545218000.0, "total_assets": 2282315000.0, "total_liabilities": 1377072000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.525727323749399, "net_margin": 0.2493825035305736, "operating_margin": 0.6503005092859465, "revenue_growth_yoy": 0.10480081077023172, "roa_avg2y": 0.10484477065251056, "roa_period_end": 0.09648317607341667, "roe_avg2y": 0.5116780544592473, "roe_period_end": 0.4038843178325 } }, { "accn": "0001823239-24-000032", "filed": "2024-02-29", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 14850000.0, "eps_diluted": 1.56, "free_cash_flow": 353720000.0, "net_income": 182037000.0, "operating_cash_flow": 368570000.0, "operating_income": 554645000.0, "revenue": 799240000.0, "stockholders_equity": 315499000.0, "total_assets": 1918276000.0, "total_liabilities": 1372915000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 4.3515668829378225, "net_margin": 0.22776262449326862, "operating_margin": 0.6939655172413793, "revenue_growth_yoy": 1.8132545811656542, "roa_avg2y": 0.1141667505496294, "roa_period_end": 0.0948961463313934, "roe_avg2y": 0.9011509616098612, "roe_period_end": 0.5769812265649019 } }, { "accn": "0001823239-23-000014", "filed": "2023-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 25408000.0, "eps_diluted": 2.36, "free_cash_flow": 126779000.0, "net_income": 88972000.0, "operating_cash_flow": 152187000.0, "operating_income": 119902000.0, "revenue": 284098000.0, "stockholders_equity": 88511000.0, "total_assets": 1270691000.0, "total_liabilities": 1115945000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 12.60798092892409, "net_margin": 0.31317362318636527, "operating_margin": 0.422044505769136, "revenue_growth_yoy": 0.9847561827581389, "roa_period_end": 0.07001859618113294, "roe_period_end": 1.0052083921772434 } }, { "accn": "0001823239-22-000012", "filed": "2022-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD" }, "fundamentals": { "capex": 17148000.0, "eps_diluted": -0.03, "free_cash_flow": 6967000.0, "net_income": -4470000.0, "operating_cash_flow": 24115000.0, "operating_income": 23988000.0, "revenue": 143140000.0 }, "period_end": "2019-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio" }, "ratios": { "net_margin": -0.031228168226910717, "operating_margin": 0.1675841833170323 } } ], "latest_filing": { "accn": "0001823239-26-000011", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001823239.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001823239.json" }, "ticker": "MRVI" }